Autoantibodies Involved in Neuropsychiatric Manifestations Associated with Systemic Lupus Erythematosus
Overview
Authors
Affiliations
In the course of Systemic Lupus Erythematosus (SLE), a variety of neuropsychiatric disturbances is reported with a prevalence ranging from 17% to 75%. The diagnosis of these syndromes is difficult and requires a careful psychiatric evaluation. Distinct autoantibodies detectable in serum or cerebrospinal fluid of patients with SLE are associated with the presence of neuropsychiatric disorders. These autoantibodies may have a pathogenic relevance in neuropsychiatric SLE or they may be merely an epiphenomenon. This review describes the various autoantibodies reported to be associated with neuropsychiatric manifestations in SLE and discusses their possible role.
The MRL Model: A Valuable Tool in Studies of Autoimmunity-Brain Interactions.
Sakic B Methods Mol Biol. 2024; 2868:221-246.
PMID: 39546233 DOI: 10.1007/978-1-0716-4200-9_12.
Dziadkowiak E, Moreira H, Buska-Mach K, Szmyrka M, Budrewicz S, Barg E Front Neurol. 2021; 12:660126.
PMID: 34744955 PMC: 8567837. DOI: 10.3389/fneur.2021.660126.
Broad Learning Enhanced H-MRS for Early Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus.
Li Y, Ge Z, Zhang Z, Shen Z, Wang Y, Zhou T Comput Math Methods Med. 2020; 2020:8874521.
PMID: 33299467 PMC: 7704182. DOI: 10.1155/2020/8874521.
Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions.
Tisseverasinghe A, Peschken C, Hitchon C Curr Rheumatol Rep. 2018; 20(12):85.
PMID: 30417270 DOI: 10.1007/s11926-018-0797-2.
Kapadia M, Bijelic D, Zhao H, Ma D, Stojanovich L, Milosevic M Acta Neuropathol Commun. 2017; 5(1):70.
PMID: 28882191 PMC: 5590168. DOI: 10.1186/s40478-017-0473-1.